Document is current

Article History

Received: 15 December 2023

Accepted: 19 February 2024

First Online: 7 March 2024

Declarations

:

: Not applicable.

: Dr. Medrea has no competing interests.Dr. Tepper’s Disclosures:Advisor, consultant, Advisory Board, and/or Scientific Board: Aeon, Abbvie,Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker.Pharmaceutical Consulting, ClearView Healthcare Partners, ClickTherapeutics,CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect,FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science.Communications, HMP Communications, Impel, Initiatior Pharma,InteractiveForums, Keyquest, Ki Health Partners, Krog and Partners, Lundbeck, M3.Global Research, Magnolia Innovation, MJH Holdings, Miravo Healthcare,Neurofront Therapeutics, Neurolief, Novartis, <i>P</i> Value Communications, Pain.Insights, Inc., Palion Medical, Pfizer, Pulmatrix, Putnam Associates, Rehaler, SAI.MedPartners, Satsuma, Scilex, Slingshot Insights, Spherix Global Insights, Strategy.Inc., Synapse Medical Communication, System Analytic, Taylor and Francis,Tegus,Teva, Theranica, Trinity Partners, Unity HA, Vial, XOC.Honoraria lecture fees, Continuing Medical Education (CME): American Academy of.Neurology, American Headache Society, Annenberg Center for Health Sciences,Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative,Haymarket Medical Education, HMP Global, Medical Education Speakers Network,Medical Learning Institute Peerview, Miller Medical Education, National Association.for Continuing Education, North American Center for CME, The Ohio State.University, Physicians’ Education Resource, PlatformQ Education, Primed, Vindico.Medical Education, WebMD/Medscape.Honoraria lecture fees/Speaker Bureau: AbbVie, Eli Lilly, Pfizer, Scilex, Teva.Research funding: Aeon, Abbvie, Eli Lilly, Lundbeck, Neurocrine, Neurolief, Pfizer,Suven, UCB.Travel: AbbVie, American Headache Society, Diamond Headache Clinic, Eli Lilly,Pfizer, Scilex.Stock, stock options, patents, royalties, manuscript fees, subsidies, endowments:None.Dr. Wang has no competing interests.Dr. Mathews has received consulting fees for Lilly and Upsher Smith.Dr. Burish was consultant for Puretech Health (in lieu of direct funding to Dr. Burish, a donation was made to a local non-profit headache foundation that funds Dr. Burish’s research). He is an unpaid member of the medical advisory board of Clusterbusters, and is a site investigator for a cluster headache clinical trial funded by Lundbeck. He was paid for a video podcast from the American Academy of Neurology.